190 related articles for article (PubMed ID: 26935231)
21. [Clinical significance of epidermal growth factor receptor and thymidylate synthase expression in primary liver cancer].
Guo FY; Yang J; Xiong SM; Zhu MQ; Gao S; Li JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):666-669. PubMed ID: 30481863
[No Abstract] [Full Text] [Related]
22. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
[TBL] [Abstract][Full Text] [Related]
23. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M
Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer.
de Almeida VH; de Melo AC; Meira DD; Pires AC; Nogueira-Rodrigues A; Pimenta-Inada HK; Alves FG; Moralez G; Thiago LS; Ferreira CG; Sternberg C
Braz J Med Biol Res; 2017 Nov; 51(1):e6822. PubMed ID: 29160417
[TBL] [Abstract][Full Text] [Related]
26. Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
Powrózek T; Kowalski DM; Krawczyk P; Ramlau R; Kucharczyk T; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Dyszkiewicz W; Krzakowski M; Milanowski J
Clin Lung Cancer; 2014 Nov; 15(6):455-65. PubMed ID: 25246386
[TBL] [Abstract][Full Text] [Related]
27. Thymidylate synthase and ERCC1 as predictive markers in patients with pulmonary adenocarcinoma treated with pemetrexed and cisplatin.
Lee SH; Noh KB; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kim CH; Kang KH; In KH
Lung Cancer; 2013 Jul; 81(1):102-8. PubMed ID: 23523421
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
29. Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapy.
Maus MK; Mack PC; Astrow SH; Stephens CL; Zeger GD; Grimminger PP; Hsiang JH; Huang E; Li T; Lara PN; Danenberg KD; Gandara DR
J Thorac Oncol; 2013 May; 8(5):582-6. PubMed ID: 23470290
[TBL] [Abstract][Full Text] [Related]
30. Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer.
Gandara DR; Grimminger P; Mack PC; Lara PN; Li T; Danenberg PV; Danenberg KD
J Thorac Oncol; 2010 Dec; 5(12):1933-8. PubMed ID: 20975603
[TBL] [Abstract][Full Text] [Related]
31. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
[TBL] [Abstract][Full Text] [Related]
32. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.
Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV
Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI.
Seo BG; Kwon HC; Oh SY; Lee S; Kim SG; Kim SH; Han H; Kim HJ
Oncol Rep; 2009 Jul; 22(1):127-36. PubMed ID: 19513514
[TBL] [Abstract][Full Text] [Related]
34. ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer.
Choueiri MB; Shen JP; Gross AM; Huang JK; Ideker T; Fanta P
PLoS One; 2015; 10(6):e0126898. PubMed ID: 26083491
[TBL] [Abstract][Full Text] [Related]
35. EGFR exon 19-deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non-small cell lung cancer.
Zhang L; Pradhan B; Guo L; Meng F; Zhong D
Thorac Cancer; 2020 Feb; 11(2):277-285. PubMed ID: 31875360
[TBL] [Abstract][Full Text] [Related]
36. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
Joshi MB; Shirota Y; Danenberg KD; Conlon DH; Salonga DS; Herndon JE; Danenberg PV; Harpole DH
Clin Cancer Res; 2005 Mar; 11(6):2215-21. PubMed ID: 15788669
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis.
Silva Amancio AM; Cunha IW; Neves JI; Quetz JD; Carraro DM; Rocha RM; Zequi SC; Cubilla AL; da Fonseca FP; Lopes A; Cunha MD; Lima MV; Vassallo J; Guimarães GC; Soares FA
Hum Pathol; 2017 Mar; 61():97-104. PubMed ID: 27864120
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients.
Yu D; Li J; Han Y; Liu S; Xiao N; Li Y; Sun X; Liu Z
Chin Med J (Engl); 2014; 127(8):1464-8. PubMed ID: 24762590
[TBL] [Abstract][Full Text] [Related]
39. Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors.
Monica V; Familiari U; Chiusa L; Rossi G; Novero D; Busso S; Ruffini E; Ardissone F; Scagliotti GV; Papotti M
Lung Cancer; 2013 Mar; 79(3):228-35. PubMed ID: 23276504
[TBL] [Abstract][Full Text] [Related]
40. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.
Metzger R; Leichman CG; Danenberg KD; Danenberg PV; Lenz HJ; Hayashi K; Groshen S; Salonga D; Cohen H; Laine L; Crookes P; Silberman H; Baranda J; Konda B; Leichman L
J Clin Oncol; 1998 Jan; 16(1):309-16. PubMed ID: 9440758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]